fashion -WSS

fashion

author：explore 2025-10-01 15:40:08 - browse：9

Stock photograph of a tall pile of journals or magazines on a black background — Adobe

There was a time when an allegation of data mishandling, scientific misconduct, or just a technical error felt like a crisis to Barrett Rollins, an oncologist and research integrity officer at Dana-Farber Cancer Institute. Now, it’s a Tuesday.

The renowned cancer treatment and research center is in the midst of a lengthy review of possible discrepancies involving around 60 papers co-authored by four of its top researchers over a period of over 15 years, including CEO Laurie Glimcher and COO William Hahn. And it’s hardly alone. Over the past decade, the number of research misconduct allegations reported to the National Institutes of Health has more than doubled, climbing from 74 in 2013 to 169 in 2022. And scientific sleuths are finding plenty of other problems that don’t always qualify as outright misconduct.

One analysis of PubPeer, a website where users can anonymously comment on scientific papers, found that out of a sample of nearly 25,000 comments, 62% were about alleged data manipulation. Nearly 80% of these comments were on health or life sciences studies.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： Readout LOUD podcast: FTC v. biotech, future of Pfizer and Vertex

WSS

Doctors' information doesn't help them choose wisely when sick

Readout LOUD podcast: FTC v. biotech, future of Pfizer and Vertex

Readout LOUD podcast: FTC v. biotech, future of Pfizer and Vertex

GSK to buy asthma

Gilead acquiring CymaBay and its liver disease drug for $4.3 billion

Heart disease and mental health: A look at cardiac psychology

hotspot

fashion

explore

Psychedelics group wrestles with new pharma identity

Risky weight loss products often used by teens globally, per study

United colonoscopy coverage change 'may cost lives,' doctors say

Why did Pfizer dish out millions for a Super Bowl ad?

Sports medicine is finally prioritizing gender equality

Risky weight loss products often used by teens globally, per study

BioMarin wins approval for gene therapy to treat hemophilia A

New menopause drug shows promise in relief for hot flashes

BioMarin wins approval for gene therapy to treat hemophilia A

The Readout: Gilead, Bernie Sanders, and other pharma news

hotspot

Readout Newsletter: Biogen, Rocket Pharma, KalVista, and more

Heart disease and mental health: A look at cardiac psychology

Medical mystery: When a cough is not just a cough

Doudna institute plans to 'cure hundreds of diseases' with CRISPR

New Medicare drug pricing powers could soon be upended in court

Readout LOUD podcast: How biotech is using artificial intelligence

hotspot

knowledge

Wikipedia

focus